Better Therapeutics Inc Stock Ownership - Who owns Better Therapeutics?

Insider buying vs selling

Have Better Therapeutics Inc insiders been buying or selling?
Andrew J. ArmaninoDirector2023-07-27274,010$0.73
Mark A. BermanChief Medical Officer2023-07-2754,802$0.73
Geoffrey M. ParkerDirector2023-07-27685,025$0.73
Frank KarbeChief Executive Officer2023-07-27137,005$0.73
Elder GrangerDirector2023-07-2734,251$0.73
David P. PerryExecutive Chairman2023-07-271,233,045$0.73
Elder GrangerDirector2023-05-16600$0.87
Andrew J. ArmaninoDirector2023-04-10303,030$0.83
Frank KarbeChief Executive Officer President Treasurer and Secretary2023-04-10242,424$0.83
Geoffrey M. ParkerDirector2023-04-10303,030$0.83

1 of 2

BTTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BTTX insiders and whales buy or sell their stock.

BTTX Shareholders

What type of owners hold Better Therapeutics Inc stock?
David P. Perry67.89%27,546,794$9.37MInsider
Mauleffinch 2015 Trust Georgianna8.96%3,636,364$1.24MInsider
Kevin J. Appelbaum5.95%2,412,969$820.41kInsider
Mountain Crest Capital LLC3.39%1,374,000$467.16kInsider
Dong Liu3.39%1,374,000$467.16kInsider
Geoffrey M. Parker2.66%1,081,388$367.67kInsider
Andrew J. Armanino1.86%756,702$257.28kInsider
Vanguard Group Inc1.08%438,479$149.08kInstitution
Frank Karbe1.06%429,429$146.01kInsider
Mark A. Berman0.96%388,191$131.98kInsider

1 of 3

BTTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BTTX2.66%97.34%Net BuyingNet Buying
SRZN31.56%68.44%Net Buying
GOVX0.62%99.38%Net BuyingNet Buying
FREQ13.18%16.71%Net SellingNet Selling

Better Therapeutics Stock Ownership FAQ

Who owns Better Therapeutics?

Better Therapeutics (NASDAQ: BTTX) is owned by 2.66% institutional shareholders, 97.54% Better Therapeutics insiders, and 0.00% retail investors. David P. Perry is the largest individual Better Therapeutics shareholder, owning 27.55M shares representing 67.89% of the company. David P. Perry's Better Therapeutics shares are currently valued at $9.37M.

If you're new to stock investing, here's how to buy Better Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.